680 related articles for article (PubMed ID: 19493292)
1. Correlation between Lower Urinary Tract Symptoms (LUTS) and sexual function in benign prostatic hyperplasia: impact of treatment of LUTS on sexual function.
Jung JH; Jae SU; Kam SC; Hyun JS
J Sex Med; 2009 Aug; 6(8):2299-304. PubMed ID: 19493292
[TBL] [Abstract][Full Text] [Related]
2. Effects of components of metabolic syndrome on sexual function in Korean BPH/LUTS patients.
Lee SH; Kim JC; Lee JY; Kim JH; Oh CY; Lee SW; Yoo SJ; Chung BH
J Sex Med; 2009 Aug; 6(8):2292-8. PubMed ID: 19493291
[TBL] [Abstract][Full Text] [Related]
3. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
Lee JH; Kwon H; Park YW
Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
[TBL] [Abstract][Full Text] [Related]
4. Treatment with a uroselective α1-blocker improves voiding and sexual function: a study in Thai men with lower urinary tract symptoms.
Permpongkosol S; Krilad-O-Larn S; Ratana-O-Larn K
J Sex Med; 2011 Sep; 8(9):2582-9. PubMed ID: 21699664
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results from a cross-sectional study.
Russo GI; Cimino S; Fragalà E; Privitera S; La Vignera S; Condorelli R; Calogero AE; Castelli T; Favilla V; Morgia G
J Sex Med; 2014 Aug; 11(8):2074-82. PubMed ID: 24836928
[TBL] [Abstract][Full Text] [Related]
6. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of self-estimation of disuric disorders gauged IPSS scale and qualities of lives QoL with self-estimation of sexual life gauged by IIEF-5 scale].
Lipczyński W; Dobrowolska-Glazar B; Dobrowolski ZF
Przegl Lek; 2012; 69(6):247-52. PubMed ID: 23094437
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of sexual function in men with symptomatic benign prostatic hyperplasia].
Shao Q; Song J; Guo YW; Lu WC; Du LD
Zhonghua Nan Ke Xue; 2005 Jul; 11(7):505-7. PubMed ID: 16078666
[TBL] [Abstract][Full Text] [Related]
9. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report.
Liguori G; Trombetta C; De Giorgi G; Pomara G; Maio G; Vecchio D; Ocello G; Ollandini G; Bucci S; Belgrano E
J Sex Med; 2009 Feb; 6(2):544-52. PubMed ID: 19138360
[TBL] [Abstract][Full Text] [Related]
11. Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction.
Kardasevic A; Milicevic S
Med Arch; 2017 Feb; 71(1):32-36. PubMed ID: 28428671
[TBL] [Abstract][Full Text] [Related]
12. Relationships between lower urinary tract symptoms, the bother they induce and erectile dysfunction.
Ströberg P; Boman H; Gellerstedt M; Hedelin H
Scand J Urol Nephrol; 2006; 40(4):307-12. PubMed ID: 16916772
[TBL] [Abstract][Full Text] [Related]
13. Effect of selective alpha-blocker tamsulosin on erectile function in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
Shelbaia A; Elsaied WM; Elghamrawy H; Abdullah A; Salaheldin M
Urology; 2013 Jul; 82(1):130-5. PubMed ID: 23711438
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of combination therapy with mirodenafil and α1-blocker for benign prostatic hyperplasia-induced lower urinary tract symptoms accompanied by erectile dysfunction: a multicenter, open-label, prospective study.
Lee JY; Cho SY; Oh CY; Ha US; Lee SH; Park SY; Moon HS; Lee SW
Int J Impot Res; 2011; 23(6):249-56. PubMed ID: 21814227
[TBL] [Abstract][Full Text] [Related]
15. [Sexual function of men with symptomatic benign prostatic hyperplasia and effect of Tamsulosin].
Zhang JG; Wang YL; Ren XQ; Gao ZW; Cheng YH
Zhonghua Nan Ke Xue; 2006 Aug; 12(8):723-5. PubMed ID: 16970165
[TBL] [Abstract][Full Text] [Related]
16. Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment.
Roehrborn CG; Egan KB; Miner MM; Ni X; Wong DG; Rosen RC
BJU Int; 2016 Jul; 118(1):153-60. PubMed ID: 26765325
[TBL] [Abstract][Full Text] [Related]
17. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Stief CG; Porst H; Neuser D; Beneke M; Ulbrich E
Eur Urol; 2008 Jun; 53(6):1236-44. PubMed ID: 18281145
[TBL] [Abstract][Full Text] [Related]
18. Impact of lower urinary tract symptoms/benign prostatic hyperplasia treatment with tamsulosin and solifenacin combination therapy on erectile function.
Seo DH; Kam SC; Hyun JS
Korean J Urol; 2011 Jan; 52(1):49-54. PubMed ID: 21344031
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of PDE5 inhibitors alone or in combination with alpha-blockers for the treatment of erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and meta-analysis.
Yan H; Zong H; Cui Y; Li N; Zhang Y
J Sex Med; 2014 Jun; 11(6):1539-45. PubMed ID: 24621088
[TBL] [Abstract][Full Text] [Related]
20. Sexual dysfunction in aging men with lower urinary tract symptoms.
Mehraban D; Naderi GH; Yahyazadeh SR; Amirchaghmaghi M
Urol J; 2008; 5(4):260-4. PubMed ID: 19101901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]